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Abstract: Biological tissue consists of populations of cells exhibiting different response to 15 
pharmacological stimuli. To probe the heterogeneity of cell function, we propose a multiplexed 16 
approach based on real-time imaging of the secondary messenger levels within each cell of the 17 
tissue, followed by extraction of the changes of single-cell fluorescence over time. By utilizing a 18 
piece-wise baseline correction, we were able to quantify the effects of multiple pharmacological 19 
stimuli added and removed sequentially to pancreatic islets of Langerhans, thereby performing a 20 
deep functional profiling for each cell within the islet. Cluster analysis based on the functional 21 
profile demonstrated dose-dependent changes in statistical inter-relationships between islet cell 22 
populations. We therefore believe that the functional cytometric approach can be used for routine 23 
quantitative profiling of the tissue for drug screening or pathological testing. 24 
Keywords: Time-lapse imaging; fluorescence; cell profiling; baseline correction; antidiabetic drugs 25 
 26 
Word count: 4471 27 
Abbreviations: 28 
GLP-1, glucagon-like peptide- 1; GLP-1 (9-36), inactive form of glucagon-like peptide-1; YFP, 29 
yellow fluorescent protein; DPP-4, dipeptidyl peptidase 4; GIP, glucose-dependent insulinotropic 30 
peptide. 31 
  32 
J. Imaging 2020, 6, x FOR PEER REVIEW 3 of 29 
Introduction 33 
Biological tissue is an ensemble of cells implementing a specific common function. These are 34 
frequently cells of different types, each type running a different ‘subroutine’ of the main functional 35 
program. An example of this arrangement is pancreatic islet of Langerhans, in which cells secreting 36 
a glucose-lowering hormone insulin (β-cells) are positioned next to their counter-parts secreting 37 
glucagon (α-cells) that, in turn, elevates blood glucose [1]. The unwritten biological convention is that 38 
all the cells of the same type are roughly alike. For instance, it is believed that the mutations in an 39 
energy-sensing molecule (the so called ATP-sensitive K+ (KATP) [2-4] channel) render roughly all 40 
pancreatic islet β-cells incapable of sensing blood glucose. At the same time, adrenaline is believed 41 
to induce secretion of glucagon from roughly all α-cells [5,6], to rescue the body from hypoglycemia.  42 
Whilst valid in a broad sense, this assumption, however, has its limits, as different cells of the 43 
same type are not absolutely identical.  This phenotypical heterogeneity may stem from an exposure 44 
to different factors of microenvironment [7], such as neighboring cells [8], local signals [9] or 45 
biological polarity [10]. Secondly, biological responses have stochastic molecular nature, which 46 
makes them subject to variability. For the examples above, energy sensing by the KATP channel is 47 
based on its ability to bind the molecule of ATP [11,12], whilst the α-cell sensitivity to adrenaline 48 
stems from how densely the β-adrenergic receptors are expressed on its membrane.  49 
The heterogeneity of cell phenotype can be probed by flow cytometry, a high-throughput 50 
technology that reports the expression of several proteins on the membrane of the same cell at once, 51 
by staining the cell suspension with monoclonal antibodies conjugated with fluorescent markers. 52 
Deep phenotypical profiling of living cells, arranged into an intact tissue, is done via high-content 53 
microscopy [13,14], which also characterizes specific proteins expressed on the plasma membrane. 54 
An obvious shortcoming of these otherwise powerful profiling techniques is their reliance on cell 55 
structure, which is not equivalent to the true function of the living cells. A more function-oriented 56 
approach, real-time imaging of the intracellular levels of secondary messenger compounds, such as 57 
cAMP or Ca2+, with fluorescent sensors, can profile the subpopulations of cells via specific 58 
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pharmacological stimuli [5,15,16], the so called ‘marker compounds’ [17]. The real-time imaging, 59 
however, cannot match the statistical power of the approaches above, due to a lower throughput and 60 
an increased experimental duration. Imaging of a response to a single specific stimulus may take tens 61 
of minutes, and the responses to stimuli added sequentially are difficult to interpret due time-62 
dependent drift of fluorescence.  63 
In this paper, we aimed to develop an experimental and analytical framework for deep profiling 64 
of large populations of intact living cells based on differential response to multiple pharmacological 65 
compound(s). We specifically focus on pancreatic islets of Langerhans as a model and image the 66 
cytosolic level of the secondary messenger cAMP, as this compound (i) changes on a slow (minutes) 67 
timescale, which is advantageous for imaging of large cell populations, and (ii) cannot be transmitted 68 
between two neighboring cells, unlike cytosolic Ca2+ or electrical potential of plasma membrane.  69 
Importantly, cAMP signaling in pancreatic islet cells is a target of physiological regulation by 70 
incretins, natural highly selective insulinotropic peptide agents secreted by the gut cells. Glucagon-71 
like peptide-1 (GLP-1), secreted by the gut L-cells; enhances the secretion of insulin and attenuates 72 
secretion of glucagon, in a glucose-dependent manner [18]. This mode of action makes GLP-1 an 73 
excellent anti-diabetic medication as per se it is not able to induce hypoglycemia, a major problem 74 
with many antidiabetic drugs. The active form of GLP-1 (known as ‘7-36’ form) has a short lifetime 75 
in circulation as it is rapidly inactivated by a ubiquitous enzyme, dipeptidyl peptidase-4 (DPP-4), to 76 
the inactive ‘9-36’ form. Gastric inhibitory peptide (GIP), secreted by the gut K-cells effectively works 77 
in a way similar to that of GLP-1’s, inclusive of being inactivated by DPP-4 [19]. The two key 78 
differences between the GLP-1 and GIP action are (i) the lack of inhibition of glucagon secretion and 79 
(ii) less reliable and therefore yet unexplored therapeutic perspectives of the latter, as exogenous GIP 80 
has only a small effect in human patients [19]. 81 
Critical steps in imaging of intracellular concentration of cAMP ([cAMP]i) were achieved upon 82 
development of a fluorescent genetically encoded sensors able to report submicromollar changes in  83 
[cAMP] [20] as well as the activity of proteins kinase A (PKA) [21], a parameter that is directly 84 
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dependent on [cAMP]i. We utilized the PKA and cAMP sensors for deep multifactor (ca.10 agonists) 85 
profiling of 100s…10000s of cells obtained throughout long (multi-hour) recording periods on an 86 
automatic imaging system. 87 
Materials and methods 88 
Animals and islet isolation 89 
All mouse experiments were conducted in accordance with the United Kingdom Animals 90 
(Scientific Procedures) Act (1986) and the University of Oxford ethical guidelines. C57Bl6 mice 91 
(Charles River, Harlow, UK) were killed by cervical dislocation and pancreatic islets were isolated as 92 
detailed in [24]. Islets were cultured in RPMI medium containing 11mM glucose, supplemented with 93 
10% FBS, 100IU/mL penicillin and 100μg/mL streptomycin (all reagents from Life Technologies, 94 
Paisley, UK) in absolute humidity in the atmosphere with 5% CO2. The recombinant sensors of 95 
[cAMP]i and PKA activity were delivered using adenoviral vectors at 105 infectious units per islet 96 
[22], followed by 24-36h culturing (as above) required for the expression of the reporter proteins. 97 
Imaging 98 
Imaging experiments were performed using the chamber [23], modified as reported [24]. Groups 99 
of islets were loaded on the nylon mesh inside the silicone basin of the chamber using an automatic 100 
pipette, and immobilized by a gentle pressure from above, using a 24×40×0.17 mm glass coverslip 101 
(Menzel Gläser) (Figure 1A). The sides of the coverslip were dry-sealed to the silicone of the chamber 102 
by applying a gentle pressure. Immobilized within the chamber, the islets were perifused with the 103 
bath solution at 50 μL/min, using a peristaltic pump. The bath solution contained, mM: 140 NaCl, 4.6 104 
KCl, 2.6 CaCl2, 1.2 MgCl2, 1 NaH2PO4, 5 NaHCO3, 10 glucose, 10 HEPES (pH 7.4, with NaOH) as well 105 
as the pharmacological agents, as indicated. The addition/removal of the drugs was recorded as a 106 
timestamps vector during the experiment. The imaging chamber was positioned within the 107 
temperature-controlled stage (+34°C) of a wide-field Axiozoom.V16 microscope (Carl Zeiss). 108 
J. Imaging 2020, 6, x FOR PEER REVIEW 6 of 29 
The signal in pancreatic islet cells was reported using recombinant probe AKAR3, a fusion of a 109 
molecule of CFP, a modified YFP variant (‘Venus’), covalently linked by a PKA-sensitive forkhead-110 
associated domain (FHA) [21]. Upon excitation at 430/24 nm, the CFP domain emits at 470/24 nm, as 111 
was detected using the respective filter set. An increase in the PKA activity changes the FHA 112 
conformation, which, in turn, brings the CFP and YFP domains of the sensor in close proximity. In 113 
this case, the energy of the excited CFP domain excites the YFP domain via the Förster resonance 114 
energy transfer (FRET), which results in YFP emission detected at 535/30 nm [25]. Importantly, YFP 115 
is practically not excited at the CFP excitation wavelength, 430/24 nm [26]. Time-lapse imaging of 116 
[cAMP]i was performed using recombinant Green Upward cADDis sensor (Montana Molecular, 117 
Bozeman, Montana, U.S.A.) using the same microscopic system. The cADDis represents a single-118 
fluorophore system that increases its fluorescence intensity in response to the increases in [cAMP]i. 119 
The cADDis fluorescence was excited at 470/40 nm and the emission recorded at 525/50 nm. PKA and 120 
cAMP were imaged in the islets every 60 s (16 mHz). 121 
Image analysis 122 
Image sequences were analyzed (registration, background subtraction, intensity vs time 123 
analysis) using open-source FIJI software (http://fiji.sc/Fiji). The alignment of the two emission 124 
channels, corresponding to CFP and YFP, respectively, was adjusted off-line, using Cairn Image 125 
Splitter plug-in to FIJI [27] (Cairn Research) (Figure 1B). Individual cells were detected in the 126 
fluorescence images as intensity maxima of the YFP channel, as detailed in [28]. Briefly, average 127 
intensity projection of the recorded YFP time-lapse was used as a pattern image for detection of the 128 
regions of interest (ROI): 129 
 130 
𝐼(̅𝑥, 𝑦)𝑡 =  
∑ 𝐼(𝑥,𝑦,𝑡)𝑁𝑡=1
𝑁
     (1)  131 
 132 
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where 𝐼(𝑥, 𝑦, 𝑡) is the intensity a pixel of the original 3-D image stack, with the linear coordinates 133 
𝑥 and 𝑦, N is the stack size (total number of time-points), t is the time and 𝐼(̅𝑥, 𝑦)𝑡 is the intensity of a 134 
the respective pixel of the transformed 2D image. 135 
The intensity maxima were detected [29] by (i) detecting the local maxima of the image, based 136 
on the selected threshold intensity difference between the local pixels, 𝐼𝑝𝑟𝑜𝑚, and (ii) performing a 137 
flood fill around each identified maxima based on a tolerance threshold, 𝑘𝑡𝑜𝑙 . The separate 138 
thresholded areas were recognized as regions of interest (ROI) [30], the objects of linear sizes >30 μm 139 
having been excluded as artefacts. The mean grayscale intensity 𝐼(̅𝑐𝑖 , 𝑡𝑗) was then calculated for each 140 
of the m identified ROI (ci) within each of the n timeframes (tj) of the image, separately for the CFP 141 
and YFP channel images, resulting in a 2-D intensity vs time matrix: 142 
 143 
𝐼𝑖𝑣𝑡 = (
𝐼(̅𝑐1, 𝑡1) … 𝐼(̅𝑐𝑚 , 𝑡1)
… 𝐼(̅𝑐𝑖 , 𝑡𝑗) …
𝐼(̅𝑐1, 𝑡𝑛) … 𝐼(̅𝑐𝑚 , 𝑡𝑛)
)    (2)  144 
Time-lapse data analysis 145 




) was then analyzed using IgorPro package (Wavemetrics) [28]. 146 
The raw data was expressed as the per-element ratio (R) of the intensity of the YFP to CFP channels 147 





      (3)  149 
 150 
To account for the variations caused by the differences in the expression of the recombinant 151 
sensor, the data was presented as R/R0 (Figure 2b), for which each column of the 2D matrix of the 152 
intensity ratios R was normalized by the vector of the initial intensities for each ROI, R0, which was 153 
computed as an average fluorescence within first five time points: 154 
 155 
𝑅0 = {∑ 𝑅1,𝑡
5
𝑡=1 … ∑ 𝑅𝑚,𝑡
5
𝑡=1 }     (4)  156 
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The time-dependent drift of the sensor fluorescence was derived by recurrently imposing basal 158 
conditions, corresponding to the lack of any (ant)agonist on the experimental sample, throughout the 159 
experiment. Every return to the basal conditions (timepoints denoted below as “𝑡𝑏𝑎𝑠𝑎𝑙”) was assumed 160 
to restore the initial levels of the analyte (PKA activity or [cAMP]i), independently of other factors. 161 
An individual baseline trace was generated for each column of the R/R0 matrix by interpolating 162 
(Levenberg-Marquardt least-squares) the column data corresponding to multiple 𝑡𝑏𝑎𝑠𝑎𝑙  and 163 
subtracted subsequently from the R/R0 data.  164 
We compared several interpolation functions. For linear and exponential interpolation, the first 165 
and the last of the 𝑡𝑏𝑎𝑠𝑎𝑙  regions (“R0” in Figure S1a,b) were used, whereas cubic B-spline and 166 
polynomial interpolation utilized all the 𝑡𝑏𝑎𝑠𝑎𝑙  regions (multiple R0s in Figure S1 c,d). The degree of 167 
the polynomial was chosen equal to the number of the basal regions minus one. Piece-wise baseline 168 
functions (Figure S1 e,f) were generated using linear (Figure S1 E) or square (Figure S1 f) fit of each 169 
non-basal region, using the two nearest, preceding and succeeding, 𝑡𝑏𝑎𝑠𝑎𝑙  regions. 170 
To quantify the effects of various (ant)agonists on the analyte, the 𝑡𝑏𝑎𝑠𝑎𝑙  regions were expanded 171 
to include 20 timepoints following the addition of the agent, each expanded region including the data 172 
corresponding to both basal and experimental conditions (Figure S2 b-f). To quantify the effect for 173 
each column of the R/R0 matrix, the data within each expanded region was approximated with linear 174 
(Figure S2 b), square (Figure S2 c), sigmoidal (Figure S2 e) of Hill (Figure S2 f) functions.   175 
Sorting of the columns within the R/R0 matrix (Figure 3 b,c,d) was based on the increase of the 176 
data variance following the application of the (ant)agonist. A data range corresponding to 20 177 
timepoints before and after (10+10) the application of the agonist was selected and a sorting statistic 178 
was calculated for every row of the R/R0 matrix: 179 
 180 
𝑆𝑠 = 𝑠𝑔𝑛(?̅?/?̅?0 − 1) × 𝜎?̅?/?̅?0      (5)  181 
 182 
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where ?̅?/?̅?0 and 𝜎?̅?/?̅?0 are the average R/R0 and the standard deviation of the selected range. 183 
Statistics 184 
 Statistical analysis was performed using R [31]. Hierarchical clustering with the Ward’s 185 
agglomeration method was done using the hclust function from the core R distribution. The k-means 186 
cluster analysis was performed using the kmeans function of the R core and visualized using the 187 
factoextra library. The optimal number of clusters was calculated using the elbow method 188 
implemented in the NbClust library. Sample sizes are specified in the Figure legends. 189 
Results 190 
The conditions of the adenoviral infection were optimized to allow the expression of the 191 
recombinant sensor in the predominant majority of the islet cells, whilst avoiding cell death or 192 
damage (Figure 1B). To verify the fact that we can reliably image the changes in [cAMP]i and PKA 193 
activity, a conventional positive control was applied using the combination of two known agonists, 194 
forskolin (10 μM) and 3-isobutyl-1-methylxantine (IBMX, 100 μM). The two chemicals reversibly act 195 
on intracellular enzymes, adenylyl cyclase and phosphodiesterase, respectively, to elevate the 196 
cytosolic concentration of cAMP and hence activate PKA. In our hands, the application of forskolin 197 
and IBMX reversibly increased the fluorescence of the YFP channel and decreased the fluorescence 198 
of the CFP channel of the ACAR3 sensor (Figure 1c,d). The onset of the increase in the YFP/CFP ratio 199 
coincided with an increase in [cAMP]i imaged simultaneously in a different islet positioned within 200 
the same chamber, using Green Downward cADDis sensor (Figure 1d). The [cAMP]i signal was, 201 
however, faster to relax to its basal value than the PKA signal, upon removal of forskolin and IBMX 202 
(Figure 1d).   203 
The specific agonists, GLP-1 and GIP were applied at three different concentrations, 1 pM, 100 204 
pM and 10 nM, followed by returns to the basal condition (imaging solution supplemented with 10 205 
mM glucose). The agonists induced reversible changes in the YFP/CFP fluorescence ratio (R) (Figure 206 
2a). To identify α-cells within the islets, we then applied 10 μM adrenaline, which is known to elevate 207 
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[cAMP]i selectively in these cells but, in contrast, inhibit the cAMP signaling in other types of islet 208 
cells [32]. The adrenaline response in α-cells has been proved to have a strong correlation with 209 
expression of fluorescent markers under a tissue specific glucagon promoter [5].  210 
Correcting the time-dependent drift of fluorescence  211 
The raw traces demonstrated substantial cell-to-cell variation of the YFP/CFP fluorescence ratio, 212 
R, as well as the presence of a slow time-dependent trend in R kinetics (Figure 2a,b): each time the 213 
tissue was subject to the basal, agonist-free, conditions, the apparent ratio of fluorescence was 214 
decreasing with time. We accounted for the cell-to-cell variation by normalizing R of each individual 215 
cell to its value at the beginning of the experiment (R/R0, Figure 2c,d). This correction has also 216 
increased the signal-to-noise ratio (SNR, Table 1).  217 
To correct the baseline trend, we performed a subtraction of different baseline functions (Figure 218 
S1) from the R/R0 timecourse. The quality criteria for the baseline correction were (i) the enhancement 219 
of the SNR and (ii) the ability to resolve the effects of every compound added. Linear and exponential 220 
correction, relying on the first and the last 𝑡𝑏𝑎𝑠𝑎𝑙  regions (see Methods), provided a substantial 221 
improvement in the SNR (Table 1) but failed to reveal small changes in the signal, induced by 222 
adrenaline (Figure S1a,b). The high-degree polynomial and especially spline correction, utilizing all 223 
the 𝑡𝑏𝑎𝑠𝑎𝑙  regions (‘R0’ in Figure S1c,d), had a better capability for resolving the small adrenaline effect 224 
(Figure S1c,d). The latter corrections did however introduce several artefacts into the data. The 225 
piecewise approach implementing linear (Figure S1e) or square (Figure S1f) fit between each pair of 226 
neighboring 𝑡𝑏𝑎𝑠𝑎𝑙   regions resulted in a significant increase of the SNR and, in the case of the linear 227 
correction, excellent resolution of the small adrenaline effect (Figure S1e). We therefore used the 228 
piecewise linear correction as a routine throughout the study (Figure 2e,f). 229 
Scaling-up the unsupervised quantification of the effects 230 
Quantification of the (ant)agonist effects (Figure 2) assumes comparing the average R/R0 values 231 
before (red in Figure S2a) and after (blue in Figure S2a) the application of the (ant)agonists. To limit 232 
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the manual input into the image and data processing to supervision of the ROI detection and entering 233 
the timestamps vector, we sought the ways of reusing the 𝑡𝑏𝑎𝑠𝑎𝑙  regions defined during the baseline 234 
subtraction step. To that end, we algorithmically expanded the 𝑡𝑏𝑎𝑠𝑎𝑙  regions, so they included both 235 
pre- and post-effect signal (Figure 2e), and quantified the (ant)agonist effects either by fitting the 236 
signal within each region with different functions (Figure S2b,c,e,f) or as a crude difference between 237 
the final and initial fluorescence within each region (Figure S2d). In our hands, the sigmoid and Hill 238 
fit provided the best approximation of the (ant)agonist effects (Table 2). Applied to the ‘real word’ 239 
data though, the two transcendental fits did not converge in ~2-5% of cells, which prompted us to use 240 
a less precise but more stable linear fitting algorithm (Figure S2b) for the quantification of the 241 
(ant)agonist effects. 242 
Exploratory analysis of cell populations based on the response to various stimuli 243 
The incretins GLP-1 and GIP, secreted by the gut L- and K-cells, respectively, are natural peptide 244 
factors that target pancreatic islet cells and induce increases in [cAMP]i [18]. In contrast, the 245 
catecholamine adrenaline is a body’s soluble signal that has a clear differential effect on two major 246 
islet cells subpopulations: it inhibits secretion of insulin by β-cells and induces secretion of glucagon 247 
from α-cells to rescue extreme hypoglycemia [32]. The signals induced by incretins and adrenaline 248 
are mediated via changes in [cAMP]i, acting by increasing or decreasing the concentration of the 249 
secondary messenger, respectively. We therefore used adrenaline as a marker compound [17], which 250 
discriminates between β- and α-cells within the islet, thereby classifying each cell within the islet 251 
solely by its function, without any immunostaining, which would have required killing the cells and 252 
permeabilizing the cell membranes (Figure 3). To that end, having used the PKA activity as a 253 
surrogate for [cAMP]i (Figure 3a), we have ranked the imaged cells by the change in the PKA activity 254 
induced by 10 μM adrenaline (Figure 3b, arrow). Having logically sorted the heterogeneous 255 
population into α- (dashed) and β-cell populations (Figure 3b), we observed that mouse α-cells were 256 
seemingly better responsive to GLP-1 (and GIP) than β-cells (Figure 3b), in contrast with earlier 257 
reports on the limited impact of GLP-1 on [cAMP]i in α-cells [33]. Further ranking of cell responses 258 
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according to the individual cell sensitivity to GIP or GLP-1 (Figure 3c,d) suggested the most GLP-1-259 
sensitive cells to be at the same time the most GIP-sensitive, within low, physiologically relevant 260 
concentrations of the two incretins (1 and 100 pM) (Figure 3c). 261 
Multiparameter profiling of cell subpopulations within islets 262 
We have therefore computed correlations between the effects of the two incretins, GIP and GLP-263 
1, on a per-cell basis, within α- and β-cell populations. Palpable at low and intermediate 264 
concentrations (1 pM, 100 pM), positive per-cell correlation between GIP and GLP-1 effects in the β-265 
cell population was significantly decreased when the incretins were used at 10 nM (Figure 4a). A 266 
similar pattern was observed for GIP and GLP-1 9-36 (Figure 4b). Overall, despite the low potency of 267 
the inactive form of GLP-1 (9-36) (Figure 3d), the effects of the two forms of GLP-1 appeared to 268 
associate in statistical sense, in the β-cells (Figure 4c), inclusive of the concentration-dependent 269 
decline in correlation with GIP (cf. response to 100 pM and 10 nM among the red markers in Figure 270 
4a,b). For α-cells, however, the correlation between the effects of GLP-1 and GIP, at physiologically 271 
relevant concentrations of 1 and 100 pM, was negative, which, just like in the case of β-cells, was 272 
attenuated at the higher concentration of the agonists (blue in Figure 4b). 273 
Clusters of islet cells responding to the incretin signals  274 
We further probed the association of the incretin effects in two main islet cell populations, α- 275 
and β-cells, by performing the cluster analysis of the functional response to three concentrations (1 276 
pM, 100 pM, 10 nM) of the agonists from 6 pancreatic islet preparations (n=10,294 cells). The k-means 277 
cluster analysis (Figure 5a,b) allowed mapping of five (for β-cells) and four (α-cells) functionally 278 
distinct subpopulations (Figure 5ab). The major contributors into the principal component 1 (PC 1) 279 
were the effects of the three concentrations of GLP-1 whereas PC 2 is mostly influenced by GLP-1 (9-280 
36) (Table S1, Table S2), for both α- and β-cells.      281 
The hierarchical clustering (Figure 5c,d: dendrogram along the X-axis) revealed a strong 282 
association between the responses to the three concentrations of GLP-1 as well as between the 283 
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responses to all concentrations GLP1 (9-36) in both β- (Figure 5c) and α-cells (Figure 5d). At the same 284 
time, the response to GIP displayed non-monotonous concentration-dependent behavior (Figure 285 
5c,d): 1 and 100 pM clustered with the inactive form of GLP-1 (9-36) whereas the 10 nM data clustered 286 
with the effect of IBMX and forskolin, which directly stimulate adenylyl cyclase and inhibit 287 
phosphodiesterase.  288 
Discussion 289 
We report a framework for deep functional profiling of cell subpopulations within the living 290 
tissues. The approach, based on real-time imaging of reversible effects imposed by various 291 
physiologically relevant (ant)agonists, reflected in changes of the concentration of an intracellular 292 
messenger ([cAMP], in our case).  293 
Technical aspects 294 
Cell detection 295 
The key weakness of wide-field epifluorescence microscopy is the out-of-focus fluorescence 296 
resulting in a poor discrimination of the signal between neighboring cells, which renders the 297 
technique unusable for true 3D imaging. Whilst allowing a better cancellation of the out-of-focus 298 
light, laser scanning confocal microscopy delivers a lower signal-to-noise ratio [5]. The latter 299 
represents a critical issue for imaging of large populations that benefits from the large field-of-view 300 
typical for lower magnification objectives that tend to have a lower numerical aperture and hence 301 
lower sensitivity. In our case, a compromise solution is a 2D imaging of the cells lying on the 302 
periphery of the tissue that stems from the expression pattern of the fluorescent reporter delivered 303 
by an adenovirus [5,24].  304 
A strong advantage of the genetically encoded sensor is that its fluorescence is strictly contained 305 
to the cells thereby limiting the extracellular artefacts and simplifying the detection of cells. In our 306 
system where CFP is perfectly colocalized with YFP in the cell, as two domains of the same molecule, 307 
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we used the brighter YFP channel to map the ROIs. Rather than performing a pixel-by-pixel ratio of 308 
YFP and CFP fluorescence intensity use ROI-by-ROI ratio to reduce noise stemming from any small 309 
misalignment of the two channels.  310 
Choice of the reporter 311 
The wide variety of the receptor proteins residing on the cell membrane sense a plenitude of 312 
extracellular stimuli, which converges into a very limited number of intracellular signals, such as 313 
Ca2+, diacyl glycerol and cAMP. Of the three signals, [Ca2+]i assays has historically seen the greatest 314 
progress, due to the triggering nature of this signal and its close association with cell membrane 315 
excitability. However, imaging of [Ca2+]i is less compatible with large sample sizes and experimental 316 
duration due to the demand for a high acquisition rate (ca.10s) needed to resolve calcium dynamics. 317 
In this sense, long large-sample-size recordings favor slower, less “regenerative” signals, such as 318 
[cAMP]i, that can be imaged on a minutes timescale and reflect equally high number of signaling 319 
pathways thereby guaranteeing the profiling depth. The obvious down side of this choice is a 320 
relatively narrower offer of the recombinant [cAMP]i sensors.  321 
Depth of profiling 322 
The practical determinant of the depth of the cell profiling in our system (=ability to record the 323 
effects of multiple agonists added sequentially to the same cell) is the maximal duration of the 324 
experiment. Having minimized the exposure to the exciting light by the choice of the sensor, we 325 
attenuate its effect on cell viability and the brightness of the fluorescent sensor. The remaining ‘real 326 
world’ factor limiting the recording duration is the mechanical stability of the imaged object. Whereas 327 
small movements can be accounted by the existing image registration routines [34], a rapid or 328 
substantial motion cannot be corrected analytically. Our approach to this problem was avoiding the 329 
motion by applying a small mechanical pressure on the imaged object [24]. Furthermore, the use of 330 
the open-air design [24,35], whereby the solution is blotted through the imaging chamber [24], 331 
dampens any pulsations  and removes the air bubbles produced by pumping and liquid handling.  332 
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Baseline correction 333 
Oxygen-dependent reduction of the sensor fluorescence (photobleaching) is proportional to the 334 
excitation power [36,37], thus minimizing that whilst using a longer exposure times allows 335 
monitoring the dynamics of slow (0.5-1 minute acquisition intervals) signals reliably for about 2 336 
hours, after which the baseline correction becomes vital. The ratiometric nature of the PKA sensor 337 
employed in this study does not rescue the baseline drift, as the photobleaching rates of the donor 338 
and the acceptor are different [38]. FRET sensors are thus paradoxically more prone to the bleaching-339 
related artefacts [39]. Likewise, the 4-fold difference in brightness (the product of the extinction and 340 
the quantum yield) of the two fluorophores [40] renders the FRET pair sensitive to factors like pH.  341 
Physiological significance 342 
Functional profiling reflects cell heterogeneity 343 
The responses to physiological stimuli subject to variability, even within a nominally 344 
homogenous cell population, as has been reported for mouse [24,41] and human [24,42] pancreatic 345 
islet cells. The islet secretory function is vastly redundant, which safeguards the control over blood 346 
glucose levels. For instance, as little as 2% (Pareto: xm=0.4, α=1), of islet’s second largest population, 347 
α-cells, are required to maintain body’s glucagon levels [43]; this figure is ca.20% (Pareto: xm=4, α=1) 348 
for less abundant δ-cells [44]. The minimal fraction of the largest islet population, β-cells, is hard to 349 
determine as these cells are electrically coupled together and therefore function as a single unit. An 350 
increase in [cAMP]i in response to 1 pM GLP-1 is a stimulus that does not propagate between 351 
neighboring cells. In our hands, [cAMP]i went up in 65%, with a potent sustained response being 352 
observed in only 15% of β-cells (Figure 3b,c). The GLP-1 responsiveness is a major factor of per-cell 353 
heterogeneity of β-cells (Figure 5a, Table S2), which echoes the GLP-1 receptor per-cell heterogeneity 354 
[45] as well as the variability of the response to the GLP-1 mimetic antidiabetic drugs among human 355 
patients [46].     356 
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Pharmacology of cell populations 357 
In our hands, the responses to low (physiological) doses of GIP clustered with the responses to 358 
inactive (9-36) form of GLP-1 (Figure 5a,b), whereas, the responses to high (potentially, therapeutical) 359 
doses of GIP clustered with that of direct agonists of adenylyl cyclase (forskolin) (Figure 5a,b), for 360 
both β- and α-cells. Different concentrations of GIP are therefore likely to act via different routes, 361 
possibly via receptors of different affinity expressed by different cell subpopulations. The 362 
populational approach to the pharmacological data may therefore shed light on the mechanisms of 363 
action of the proven and yet-to-be discovered drugs. 364 
Conclusions 365 
We present key steps of functional profiling of living cells within the biological tissue, inclusive 366 
of imaging, image processing and data analysis. The profiling can bring novel insights into yet 367 
unstudied aspects of human physiology thereby contributing to more specific pharmacological 368 
targeting of cell subpopulations. We expect the approach to benefit from developments in budget 369 
imaging technology, based on lab-on-a-chip or organ-on-a-chip configurations. We expect that novel 370 
recombinant sensors as well as functional data databases to further enhance the impact of our work. 371 
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Figure 1. Imaging set-up, sensor expression and the FRET channels. (a) Schematic of the imaging 506 
chamber. (b) Expression of the recombinant PKA sensor, AKAR3, in islets of Langerhans. Raw YFP, 507 
CFP channel fluorescence, imaged using epifluorescence microscopy, alignment of YFP and CFP 508 
channels, and the YFP/CFP ratio, as indicated. The individual cells (regions of interest) detected as 509 
intensity maxima, are outlined in yellow on the ratio image. (c, d) Representative changes in the raw 510 
fluorescence intensity of the YFP channel (c) corresponding to the three indicated time-points of the 511 
raw kinetics traces (d) of the YFP (top, yellow), CFP (middle cyan) channels recorded pseudo-512 
simultaneously with the fluorescence of Green Downward cADDis (bottom, green).  513 
  514 
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Figure 2. Baseline correction for populational time-lapse images. Changes in the cytosolic [cAMP] 516 
visualised via activity of PKA in response to various (ant)agonists, as indicated, recorded from a 517 
population of pancreatic islet cells. a: raw data (gray traces, gray bar) and the average±SEM trace 518 
(red). b: As in (a) but colour-coded according to the scale provided to show the response from each 519 
individual cell. c: Raw data (gray) normalised to the initial fluorescence (R/R0), as indicated, 520 
average±SEM (red). d: Colour-coded heat map of the data in (c). e: Baseline-corrected data, using the 521 
baseline reference areas indicated. f: Colour-coded data from (e). 522 
  523 
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Table 1. Signal-to-noise ratio improvement after data correction procedures.525 
Procedure SNR, a.u. Comment 
Raw data 23±5 (n=1300) Per-cell variation of fluorescence and baseline drift 
Normalised to initial ratio 256±24 Baseline drifts with time 
Linear baseline correction  322±44 Ignores small effects 
Exp baseline correction 318±40 Ignores small effects 
Spline baseline correction 385±15 Introduces artefacts 
Poly baseline correction 374±55 Ignores small effects 
Piecewise linear baseline correction 410±21 Method of choice 
Piecewise square baseline correction 395±28 Introduces artefacts 
Table 2. Root square means of differences between the agonist effect assessed via the two-region 526 
approach (Figure S2a) and single-region algorithms (Figure S2b--f). 527 
Procedure RMS vs the two-region Comment 
Two-region 0 Bona fide but time-consuming 
Linear 0.152±0.053 (n=1300) Method of choice 
Square 0.841±0.122 Introduces artefacts 
End–start 0.363±0.094 Requires smoothing, prone to artefacts 
Sigmoid 0.023±0.008 Precise but fitting needs supervision 
Hill 0.022±0.007 Previse but fitting requires supervision 
  528 
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 530 
Figure 3. Identification of cell populations based on pharmacology. a: Baseline-corrected data 531 
presented as a heat map to reflect the behavior of individual cells in response to various agonists, as 532 
indicated. b: the same data but ranked according to the response to adrenaline, a marker compound 533 
for α-cells. c, d: the same data sorted by the response to incretins GLP-1 (7-36) (c) and GIP (d). 534 
  535 
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 537 
Figure 4. Dose-dependent effects on incretins on α- and β-cell populations in pancreatic islets of 538 
Langerhans. 3D (a) and 2D (b) scatter plots reporting the effects of incretins, GLP-1, GIP and GLP-1 539 
9-36, added at 1 pM, 100 pM and 10 nM, on α- and β-cells, as indicated. α- and β-cells were 540 
distinguished by the positive and negative effect of adrenaline, respectively. The lines in (b) represent 541 
the least-squares fit, the Pearson’s R-values being given for α- and β-cell subpopulations, as indicated. 542 
The data is from 3 experiments, n=4096 cells. Correlations are statistically significant at *p<0.05 or 543 
**p<0.01. 544 
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 547 
Figure 5. Cluster analysis of the incretin responsiveness of pancreatic islet cells. a-b: k-means 548 
clustering of β- (a) and α-cell (b) populations. The linear contributions of individual factors into the 549 
first two principal components, PC 1 and PC2, are detailed in Table S2. Insets: Total within-cluster 550 
sum of squares depending on the cluster number. The plots were used to determine the optimal 551 
number of clusters. c-d: Hierarchical clustering of pancreatic β- (c) and α-cell (d) populations alongside 552 
the incretin stimuli. ‘GLP9’ denotes the inactive form of GLP-1, GLP-1 9-36. Z-score is the value 553 
relationship to the mean of the row, in the units of the standard deviation. Note a close per-cell 554 
association between the effects of lower concentrations of GIP (1 pM, 100 pM) and the inactive form 555 
of GLP-1 (9-36) as well as the effects of the high concentration of GIP (10 nM) and that of a direct 556 
stimulation of adenylate cyclase/inhibition of phosphodiesterase by forskolin and IMBX. The data is 557 
from 6 experiments, n=10,294 cells. 558 
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Supplementary figures 560 
 561 
Figure S1. Baseline correction using different algorithms. Whilst baseline correction based on 562 
simple linear (a) and exponential (b) fits resulted in an improvement of the signal-to-noise ratio, both 563 
algorithms failed to account for smaller effect like that of adrenaline. This issue was rectified using 564 
the spline (c) but not polynomial (d) correction. However, the spline algorithm failed to de-trend the 565 
time-course. Piecewise linear algorithm (e) that separated the trace into several regions between the 566 
applications of the basal conditions (R0) both de-trended the signal and resolved the small effects well. 567 
Using a higher degree piecewise fit (f), however, introduced several artefacts, just like the polynomial 568 
correction did (d). 569 
J. Imaging 2020, 6, x FOR PEER REVIEW 27 of 29 
 570 
Figure S2. Unsupervised quantification of the agonist effects. a: An ideal approach (“bona fide”) that 571 
takes the means of the two regions of fluorescence, prior and post application of the agonist (Ī1 and Ī2, 572 
respectively), for each individual cell, and computes the ratio reflecting the magnitude of the effect. 573 
The approach requires a user input step for marking the two regions. b-f: Optimization of the 574 
quantification procedure for the unsupervised single-region case. A single region containing both pre- 575 
and post-agonist signal, with subsequent quantification of the agonist effect based on linear (b), square 576 
(c), sigmoid (e), Hill (f) fit of the data within the range. The effect is then expressed as the difference 577 
in the fitted intensity computed at the points of the beginning and the end of the region. (d) simple 578 
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Table S1. Principal components of the k-means clustering (β-cells) and the contributions of the 583 
responses to the peptide agonists. 584 
 PC 1 PC 2 PC 3 PC 4 PC 5 
1 pM GIP 3.2 13.3 24.9 11.7 1.7 
100 pM GIP 2.8 15.3 28.5 1.7 0.1 
10 nM GIP 0.2 0.2 16.4 78.9 1.5 
1 pM GLP1 23.5 1.8 6.5 2.9 0.6 
100 pM GLP1 24.0 3.0 5.5 1.0 0.0 
10 nM GLP1 24.0 3.6 4.1 0.7 0.1 
1 pM GLP1 9-36 5.0 21.2 4.8 0.4 58.6 
100 pM GLP1 9-36 8.4 23.4 4.7 1.0 1.6 
10 nM GLP1 9-36 8.9 18.3 4.6 1.7 35.8 
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Table S2. Principal components of k-means clustering (α-cells) and the contributions of the 586 
responses to the peptide agonists.  587 
 PC 1 PC 2 PC 3 PC 4 PC 5 
1 pM GIP 8.9 5.6 25.2 11.4 3.9 
100 pM GIP 8.7 2.9 37.6 0.9 0.0 
10 nM GIP 0.0 3.3 19.4 69.4 2.2 
1 pM GLP1 17.8 11.2 0.4 2.1 1.1 
100 pM GLP1 16.2 16.2 0.5 0.0 1.1 
10 nM GLP1 14.7 19.0 1.0 0.0 0.4 
1 pM GLP1 9-36 6.6 22.1 2.7 0.1 64.5 
100 pM GLP1 9-36 12.4 13.8 6.9 7.3 5.7 
10 nM GLP1 9-36 14.6 6.0 6.3 8.7 21.1 
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